UCB
UCB.BR · BRU
Bulios Fair Price
204.55 €
2.3% downside
Current Price
209.3 €
According to Bulios Fair Price, UCB.BR is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
UCB SA (UCB) is a biopharmaceutical company based in Belgium, focusing on research, development, and production of medicinal products for the treatment of neurological and immunological disorders. The company specializes in medications for conditions such as epilepsy, Parkinson's disease, multiple sclerosis, and rheumatoid arthritis, among others. Their portfolio includes innovative drugs, biologic products, and prescription medications that improve the quality of life for patients suffering from these conditions. UCB also invests in research and development of new medications to provide effective and safe therapeutic options for patients worldwide. UCB SA (UCB) shares may be attractive to investors seeking investments in biopharmaceutical companies with an emphasis on innovation and treatment of neurological and immunological disorders.
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Christophe Tellier
Employees
9,000
Headquarters
Brussels
Upcoming events
Earnings
Upcoming earnings report